Works matching IS 03407004 AND DT 2000 AND VI 49 AND IP 4/5
Results: 13
The immunological effects of taxanes.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 181, doi. 10.1007/s002620000122
- By:
- Publication type:
- Article
Localization of an antibody to CD74 (MHC class II invariant chain) to human B cell lymphoma xenografts in nude mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 208, doi. 10.1007/s002620000102
- By:
- Publication type:
- Article
Influence of interferon γ on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8<sup>+</sup> cytotoxic T lymphocyte attack.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 193, doi. 10.1007/s002620000105
- By:
- Publication type:
- Article
Conference on cancer vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 281, doi. 10.1007/s002620000114
- By:
- Publication type:
- Article
New methods to approach immunotherapy of cancer – and strategies of tumours to avoid elimination : Conference report, on behalf of EUCAPS.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 276, doi. 10.1007/s002620000119
- By:
- Publication type:
- Article
Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 267, doi. 10.1007/s002620000108
- By:
- Publication type:
- Article
Functional assessment in vitro of human-complement-dependent antibody-induced cytotoxicity of neoplastic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 235, doi. 10.1007/s002620000096
- By:
- Publication type:
- Article
Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 259, doi. 10.1007/s002620000120
- By:
- Publication type:
- Article
Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 217, doi. 10.1007/s002620000109
- By:
- Publication type:
- Article
Immunological properties of a single-chain fragment of the anti-idiotypic antibody ACA125.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 186, doi. 10.1007/s002620000126
- By:
- Publication type:
- Article
Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 253, doi. 10.1007/s002620000101
- By:
- Publication type:
- Article
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 243, doi. 10.1007/s002620000115
- By:
- Publication type:
- Article
Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 4/5, p. 226, doi. 10.1007/s002620000112
- By:
- Publication type:
- Article